NCT05007223View on ClinicalTrials.gov

Skin Microbiome Profile in Hailey-Hailey Disease

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

May 8, 2020

Primary Completion Date

September 18, 2020

Study Completion Date

September 18, 2020

Conditions
Hailey-Hailey Disease
Interventions
DRUG

Doxycycline

200mg/day for 28 days(Given doxycycline to patients with Hailey-Hailey disease)

Trial Locations (1)

Unknown

GangnamSeveracne Hospital, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT05007223 - Skin Microbiome Profile in Hailey-Hailey Disease | Biotech Hunter | Biotech Hunter